(Seoul, South Korea, August 28, 2025) The 11th PMEC Korea 2025 was held in Seoul, South Korea, from August 26 to 28, attracting hundreds of pharmaceutical packaging and new materials companies from around the world. As the most influential annual event in the pharmaceutical equipment industry in Northeast Asia, this year’s exhibition focused on cutting-edge technologies and development trends in the industry. Shanghai JSD New Medical Material Co., Ltd (hereinafter referred to as “JSD”), an innovative enterprise in the field of medical new materials in China, made a stunning appearance with its core product, the BFS co-infusion cap for infusion bottles, showcasing the technological strength and innovative achievements of Chinese enterprises in the field of high-end medical packaging to the international pharmaceutical industry.
Innovative products lead industry trends
As a highlight of this exhibition, the co-injection cap for BFS infusion bottles showcased by JSD attracted great interest from many visitors. This product is specifically designed for modern BFS (blow-fill-seal) infusion bottles and is manufactured using an advanced co-injection molding process. It combines two polymer materials with different properties into one through precision injection molding technology, achieving both excellent sealing performance and a convenient user experience.
According to the person in charge of the JSD booth, traditional infusion bottle caps often struggle to balance sealing performance and ease of use. However, the co-infusion cap technology, through innovative design, uses a highly elastic material for the inner layer to ensure a tight seal, while the outer layer uses a high-strength material to ensure structural stability. This effectively prevents leakage and contamination of the medication and greatly improves the work efficiency of medical staff.
Technological breakthroughs solve industry pain points
In the medical packaging field, BFS (Blow-Fill-Seal) technology has become an important development direction for large-volume infusion packaging due to its advantages such as high sterility assurance and high degree of automation. However, the corresponding cap technology has long faced technical bottlenecks. Through continuous R&D investment, JSD has overcome key technical challenges in co-injection caps, including material compatibility, molding precision, and mass production stability.
“Our co-injection cap product has undergone rigorous compatibility testing and performance verification, and fully complies with domestic and international pharmacopoeia standards,” said the technical director of JSD at the exhibition. “This innovation not only solves the long-standing sealing problem of BFS infusion bottles, but also provides a more reliable guarantee for drug safety.”
International exchanges deepen industry cooperation
During the exhibition, the JSD booth attracted representatives from numerous pharmaceutical companies and industry experts from South Korea, Japan, Southeast Asia, and Europe. Many international buyers showed great interest in the technical parameters and application scenarios of co-injection caps and engaged in in-depth technical exchanges and business negotiations with the JSD team.
A purchasing manager at a major South Korean pharmaceutical company said, “The progress made by Chinese companies in the field of new medical materials is impressive. JSD’s co-injection cap products have found a good balance between performance and cost, providing us with new options for improving product quality.”
Looking to the future: Continuous innovation, serving the world.
The 11th PMEC Korea provided JSD with a valuable platform to showcase its innovative achievements and expand into international markets. The company’s general manager stated, “Participating in this exhibition not only showcased our products and technologies, but more importantly, it allowed us to gain a deeper understanding of the needs and trends in the international market. We will continue to increase our R&D investment, promote technological innovation in medical packaging materials, and contribute Chinese wisdom and solutions to the global healthcare industry.”
As the global medical industry continues to demand higher standards for packaging safety, convenience, and environmental friendliness, technological innovation will become the core driving force for enterprise development. Shanghai JSD New Medical Material Co., Ltd with its technological breakthroughs in co-injection cap technology, is steadily moving onto the international stage, injecting new momentum into the high-quality development of China’s medical new materials industry.
Shanghai JSD New Medical Material Co., Ltd focuses on the research and development and production of high-end medical packaging materials, and is committed to providing safe and reliable packaging solutions for pharmaceutical companies worldwide. The company consistently prioritizes technological innovation and quality, and its products have passed multiple international certifications. Its service network covers many countries and regions globally.
